Evidence map›Paper›PMID 36500227›Full record

ArticleMolecules (Basel, Switzerland)2022

Self-Assembled CuCo

Ran Lu, Wei Wang, Bo Dong, Chao Xu, Bo Li, Yong Sun, Junchao Liu, Biao Hong

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ran LuDepartment of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Wei WangDepartment of Vascular Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Bo DongDepartment of Vascular Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Chao XuDepartment of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Bo LiDepartment of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.ORCID 0000-0001-7888-7519
Yong SunDepartment of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Junchao LiuDepartment of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
Biao HongDepartment of Vascular Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Shanghai Jiao Tong University · CNFirst Affiliated Hospital of Bengbu Medical College · CN

Funding

Interdisciplinary Program of Shanghai Jiao Tong University YG2021QN66National Natural Science Foundation of China 51890892
6 · The paper itself

Abstract

Cardiovascular disease caused by atherosclerosis (AS) seriously affects human health. Photothermal therapy (PTT) brings hope to the diagnosis and treatment of AS, with the development of nanotechnology. To improve treatment efficiency, self-assembled CuCo

Indexed as

ArteritisHyperthermia, InducedNanoparticlesNeoplasmsDoxorubicinDrug Delivery SystemsHumansPhototherapyPhotothermal TherapyDoxorubicinarterial inflammationchemotherapychloroquinephotothermal therapyself-assembled CuCo2S4 nanocrystals

Identifiers

PMID36500227
PMCPMC9737671
OpenAlexW4310036526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.